These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12452466)

  • 1. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
    Farquhar C; Brown PM; Furness S
    BJOG; 2002 Nov; 109(11):1273-80. PubMed ID: 12452466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review.
    Lethaby A; Vollenhoven B; Sowter M
    BJOG; 2002 Oct; 109(10):1097-108. PubMed ID: 12387461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
    Sharma M; Buck L; Mastrogamvrakis G; Kontos K; Magos A; Taylor A
    BJOG; 2003 Jul; 110(7):712; author reply 712-3. PubMed ID: 12842071
    [No Abstract]   [Full Text] [Related]  

  • 6. Preoperative medical therapy before surgery for uterine fibroids.
    Lethaby A; Puscasiu L; Vollenhoven B
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hysterectomy and myomectomy by laparotomy.
    West CP
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):317-35. PubMed ID: 10023424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy.
    Guarnaccia MM; Rein MS
    Clin Obstet Gynecol; 2001 Jun; 44(2):385-400. PubMed ID: 11345000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
    Goldberg J; Bussard A; McNeil J; Diamond J
    Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.
    Badiani B; Chiumente M; Messori A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():84-88. PubMed ID: 29408752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
    Babashov V; Palimaka S; Blackhouse G; O'Reilly D
    Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis.
    Zhang Y; Sun L; Guo Y; Cheng J; Wang Y; Fan S; Duan H
    Obstet Gynecol Surv; 2014 Feb; 69(2):100-8. PubMed ID: 25112488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial.
    Rana D; Wu O; Cheed V; Middleton LJ; Moss J; Lumsden MA; McKinnon W; Daniels J; Sirkeci F; Manyonda I; Belli AM; McPherson K;
    BJOG; 2021 Oct; 128(11):1793-1802. PubMed ID: 34053154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GnRH agonists before surgery for uterine leiomyomas. A review.
    Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
    J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of ulipristal acetate tablets in treating patients with moderate to severe symptoms of uterine fibroids.
    Nagy B; Timár G; Józwiak-Hagymásy J; Kovács G; Merész G; Vámossy I; Ágh T; László Á; Vokó Z; Kaló Z
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():75-81. PubMed ID: 24568866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
    Saltiel E
    Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH agonist therapy before myomectomy or hysterectomy.
    Gutmann JN; Corson SL
    J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.